View news and innovations from PACK EXPO 2024
View all the latest news and innovations from PACK EXPO International 2024

Sinovac Gets Investment to Double Covid Vaccine Capacity

The Chinese pharmaceutical company raised over half a billion dollars to ramp up manufacturing.

According to a recent FiercePharma article, Sinovac Biotech has attracted a significant investment to increase manufacturing capacity for their Covid-19 vaccine. Sino Biopharmaceutical will pay $515 million for a 15.03% stake in Sinovac Life Sciences, a subsidiary of the vaccine specialist. The money will go directly to the development, manufacturing, and production capacity of their vaccine, CoronaVac.